2
项与 LP001(LintonPharm) 相关的临床试验评价LP-001注射液在健康受试者中单次及多次注射给药的安全性、耐受性和药代动力学的 I 期临床研究
主要目的:评价健康受试者单次/多次皮下注射不同剂量的LP-001的剂量耐受性和安全性;
次要目的:1)评价健康受试者单次/多次注射不同剂量LP-001注射液的药代动力学特征;2)评价健康受试者单次/多次注射不同剂量LP-001注射液的免疫原性;3)评价健康受试者单次/多次注射不同剂量LP-001注射液的药效学特征。
探索性目的及评价指标:探索分析健康受试者单次及多次注射不同剂量LP-001注射液后的PK/PD相关性。
/ Active, not recruiting临床1期 A Phase I Clinical Study Evaluating the Safety, Tolerability, and Pharmacokinetics of LP-001 Injection in Healthy Subjects Following Single and Multiple Doses
The purpose of this study is to evaluate safety, tolerability, immunogenicity, pharmacokinetics, pharmacodynamics, and efficacy of LP-001 in healthy volunteers. The study will be conducted in 2 parts: Part 1, the single ascending dose (SAD) is the first in human (FIH) study of LP-001 and Part 2, multiple ascending dose (MAD).
100 项与 LP001(LintonPharm) 相关的临床结果
100 项与 LP001(LintonPharm) 相关的转化医学
100 项与 LP001(LintonPharm) 相关的专利(医药)
100 项与 LP001(LintonPharm) 相关的药物交易